Crypto/Blockchain The age of the cryptocurrency pivot: A Mugglehead roundup Companies often pivot to cryptocurrency for a mix of financial, strategic, and psychological reasons Joseph Morton2 days ago
Crypto/Blockchain World Gold Council bridges the gap between physical bullion and digital assets This process provides security and reduces counterparty risk because investors hold legal title to the bullion Joseph Morton6 days ago
Alternative Energy Hydrogen sector faces reality check as BP, Origin, and others exit ventures Developers have cancelled nearly one in four announced ventures, equal to about 6 million tonnes per annum of planned capacity Joseph MortonAugust 26, 2025
Medical and Pharmaceutical Puma Biotechnology shares get favourable price bump on strong Q2 results The absence of negative developments over the past month has helped sentiment recover Joseph MortonAugust 11, 2025
Mining USA Rare Earth teams with ePropelled to supply drone magnets The company's systems are used in uncrewed vehicles (UAV) for air, land, and sea Joseph MortonAugust 8, 2025
Medical and Pharmaceutical Medpace Holdings stock just popped by 50%, but why? Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million Joseph MortonJuly 22, 2025
AI and Autonomy Drone manufacturer ZenaTech gets quantum tech edge Internal testing with historical open-source data has shown strong alignment with trusted weather platforms and actual outcomes Joseph MortonJuly 14, 2025
AI and Autonomy Synaptogenix pumps $100m into artificial intelligence token TAO exists at the intersection between artificial intelligence and blockchain technologies Joseph MortonJune 9, 2025
Medical and Pharmaceutical Against the rise of early onset cancer: a Mugglehead roundup Cancer treatment markets are set to expand rapidly over the next decade Joseph MortonMay 29, 2025
Medical and Pharmaceutical CG Oncology shares jump on positive clinical trial data for cancer drug The U.S. Food and Drug Administration (FDA) granted cretostimogene Fast Track and Breakthrough Therapy designations Joseph MortonApril 28, 2025